Suppr超能文献

使用已建立的肾近端小管上皮/端粒酶逆转录酶 1 细胞系构建体外先进肾脏模型用于肾毒性测定。

Advanced Kidney Models In Vitro Using the Established Cell Line Renal Proximal Tubular Epithelial/Telomerase Reverse Transcriptase1 for Nephrotoxicity Assays.

作者信息

Lacueva-Aparicio Alodia, Martínez-Gimeno Laura, Torcal Pilar, Ochoa Ignacio, Giménez Ignacio

机构信息

Renal and Cardiovascular Physiopathology (FISIOPREN), Aragon Health Science Institute, 50009 Zaragoza, Spain.

Tissue Microenvironment Lab (TME Lab), I3A, University of Zaragoza, 50018 Zaragoza, Spain.

出版信息

Biomimetics (Basel). 2024 Jul 22;9(7):446. doi: 10.3390/biomimetics9070446.

Abstract

Nephrotoxicity stands as one of the most limiting effects in the development and validation of new drugs. The kidney, among the organs evaluated in toxicity assessments, has a higher susceptibility, with nephrotoxic potential frequently evading detection until late in clinical trials. Traditional cell culture, which has been widely used for decades, does not recapitulate the structure and complexity of the native tissue, which can affect cell function, and the response to cytotoxins does not resemble what occurs in the kidney. In the current study, we aimed to address these challenges by creating in vitro kidney models that faithfully biomimic the dynamics of the renal proximal tubule, using the well-established RPTEC/TERT1 cell line. For doing so, two models were developed, one recreating tubule-like structures (2.5D model) and the other using microfluidic technology (kidney-on-a-chip). The 2.5D model allowed tubular structures to be generated in the absence of hydrogels, and the kidney-on-a-chip model allowed shear stress to be applied to the cell culture, which is a physiological stimulus in the renal tissue. After characterization of both models, different nephrotoxic compounds such as cisplatin, tacrolimus, and daunorubicin were used to study cell responses after treatment. The developed models in our study could be a valuable tool for pre-clinical nephrotoxic testing of drugs and new compounds.

摘要

肾毒性是新药研发和验证过程中最具限制作用的因素之一。在毒性评估所涉及的器官中,肾脏具有较高的易感性,肾毒性潜力往往在临床试验后期才被发现。几十年来广泛使用的传统细胞培养方法无法重现天然组织的结构和复杂性,这可能会影响细胞功能,而且对细胞毒素的反应与肾脏中的情况并不相似。在本研究中,我们旨在通过创建体外肾脏模型来应对这些挑战,该模型利用成熟的RPTEC/TERT1细胞系忠实地模拟肾近端小管的动态变化。为此,我们开发了两种模型,一种是重建管状结构的模型(2.5D模型),另一种是使用微流控技术的模型(芯片上的肾脏)。2.5D模型能够在不使用水凝胶的情况下生成管状结构,而芯片上的肾脏模型能够对细胞培养施加剪切应力,这是肾组织中的一种生理刺激。在对两种模型进行表征后,使用顺铂、他克莫司和柔红霉素等不同的肾毒性化合物来研究处理后的细胞反应。我们研究中开发的模型可能是药物和新化合物临床前肾毒性测试的宝贵工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b88/11275192/77b81de426e2/biomimetics-09-00446-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验